As some countries and companies roll out new rules to limit animal testing in pharmaceutical products designed for people, scientists are stepping in with a new way to test therapeutic drug candidates and determine drug safety and drug interactions — without using animals. The development of “chemosynthetic livers,” which could dramatically alter how drugs are made, was presented at the 247^th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society.

This month, the U.S. Department of Agriculture (USDA) and the University of Wisconsin-Madison entered into a settlement agreement resulting in a fine of $35,286.

The Federation of American Societies for Experimental Biology (FASEB) released a best practices guide designed to aid individuals and organizations in reducing the threat posed by animal rights extremists.

Doctors Target Meeting of Board of Governors on Feb. 7.